DSRU Scientific Publications
Use our keyword search facility to match our publications with your area of interest.
253 publications found, showing 141 to 160
-
The use of newly marketed drugs in children and adolescents prescribed in general practice
Wilton LV, Pearce G, Mann RD,
Pharmacoepidemiol Drug Saf. April 1999 -
Interim report on the incidence of visual field defects in patients on long term vigabatrin therapy
Wilton LV, Stephens MDB, Mann RD,
Pharmacoepidemiol Drug Saf. April 1999 -
Stevens-Johnson syndrome and antiepileptics
Dunn N, Wilton L, Shakir S,
Lancet. January 1999 -
Cough and angiotensin II receptor antagonists: Cause or confounding?
Mackay FJ, Pearce GL, Mann RD,
Br J Clin Pharmacol. January 1999 -
Design of a pilot prospective cohort study of adverse events monitored by hospital pharmacists
Martin RM, Mann RD, Hands DE, Tomlin M, Emerson A,
Int J Pharm Med. January 1999 -
Cardiac risks with ? agonists (multiple letters) [1]
Lindmark B, Martin RM, Dunn NR, Mann RD, Freemantle SN,
Thorax. December 1998 -
Risk of non-fatal cardiac failure and ischaemic heart disease with long acting ?2 agonists
Martin RM, Dunn NR, Freemantle SN, Mann RD,
Thorax. December 1998 -
Age and sex distribution of suspected adverse drug reactions to newly marketed drugs in general practice in England: Analysis of 48 cohort studies
Martin RM, Biswas PN, Freemantle SN, Pearce GL, Mann RD,
Br J Clin Pharmacol. November 1998 -
Prescription-event: Monitoring-recent progress and future horizons
Mann RD,
Br J Clin Pharmacol. September 1998 -
The outcomes of pregnancy in women exposed to newly marketed drugs in general practice in England
Wilton LV, Pearce GL, Martin RM, Mackay FJ, Mann RD,
Br J Obstet Gynaecol. August 1998 -
Trends in prescribing H2-receptor antagonists and proton pump inhibitors in primary care
Martin RM, Lim AG, Kerry SM, Hilton SR,
Aliment Pharmacol Ther. August 1998 -
Is the incidence of upper respiratory tract infection independent of drug treatment in large cohort studies of longer term use drugs?
Wilton LV, Freemantle SN, Martin R, Mann RD,
Pharmacoepidemiol Drug Saf. August 1998 -
Underreporting of suspected adverse drug reactions to newly marketed ('black triangle') drugs in general practice: Observational study
Martin RM, Kapoor KV, Wilton LV, Mann RD,
BMJ. July 1998 -
Oral contraceptives and thrombosis
Dunn N, De Caestecker L, Bigrigg A,
Curr Opin Obstet Gynecol. June 1998 -
Tolerability of alendronate. Figures given in letter were prevalences, not incidences
Mackay F, Mann RD,
BMJ (Clinical research ed ). May 1998 -
Does good practice organization improve the outcome of care for diabetic patients
Dunn N, Pickering R,
Br J Gen Pract. May 1998 -
United Kingdom experience with alendronate and oesophageal reactions
Mackay FJ, Wilton LV, Pearce GL, Freemantle SN, Mann RD,
Br J Gen Pract. April 1998 -
Inhibition of antigen-induced airway hyperresponsiveness by ultralow molecular-weight heparin
Molinari JF, Campo C, Shakir S, Ahmed T,
Am J Respir Crit Care Med. March 1998 -
Galactorrhoea with moclobemide
Dunn NR, Freemantle SN, Pearce GL, Mann RD,
Lancet. March 1998 -
The safety of risperidone: A post-marketing study on 7,684 patients
Mackay FJ, Wilton LV, Pearce GL, Freemantle SN, Mann RD,
Hum Psychopharmacol. January 1998